SCHRODINGER INC (SDGR)
US80810D1037 - Common Stock
We assign a fundamental rating of 5 out of 10 to SDGR. SDGR was compared to 40 industry peers in the Health Care Technology industry. SDGR has a great financial health rating, but its profitability evaluates not so good. SDGR is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
In the past year SDGR was profitable.
SDGR had a negative operating cash flow in the past year.
SDGR had negative earnings in 4 of the past 5 years.
In the past 5 years SDGR reported 4 times negative operating cash flow.
1.2 Ratios
SDGR has a Return On Assets of 5.07%. This is amongst the best in the industry. SDGR outperforms 89.74% of its industry peers.
With an excellent Return On Equity value of 7.42%, SDGR belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.07% | ||
| ROE | 7.42% | ||
| ROIC | N/A |
ROA(3y)-9.96%
ROA(5y)-9.8%
ROE(3y)-14.64%
ROE(5y)-14.58%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
SDGR's Profit Margin of 18.80% is amongst the best of the industry. SDGR outperforms 92.31% of its industry peers.
SDGR has a Gross Margin of 64.93%. This is comparable to the rest of the industry: SDGR outperforms 53.85% of its industry peers.
SDGR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 18.8% | ||
| GM | 64.93% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.4%
GM growth 5Y0.16%
2. Health
2.1 Basic Checks
SDGR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SDGR has more shares outstanding
SDGR has more shares outstanding than it did 5 years ago.
SDGR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 3.66 indicates that SDGR is not in any danger for bankruptcy at the moment.
SDGR has a better Altman-Z score (3.66) than 84.62% of its industry peers.
SDGR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.66 |
ROIC/WACCN/A
WACC10.5%
2.3 Liquidity
A Current Ratio of 4.25 indicates that SDGR has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.25, SDGR is in the better half of the industry, outperforming 79.49% of the companies in the same industry.
A Quick Ratio of 4.25 indicates that SDGR has no problem at all paying its short term obligations.
The Quick ratio of SDGR (4.25) is better than 79.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.25 | ||
| Quick Ratio | 4.25 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 125.78% over the past year.
SDGR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.74%.
The Revenue has been growing by 26.61% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)125.78%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-7.89%
Revenue 1Y (TTM)19.74%
Revenue growth 3Y26.08%
Revenue growth 5Y26.61%
Revenue growth Q2Q30.41%
3.2 Future
SDGR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 64.11% yearly.
SDGR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.06% yearly.
EPS Next Y-629.76%
EPS Next 2Y-157.73%
EPS Next 3Y-77.01%
EPS Next 5Y64.11%
Revenue Next Year-6.56%
Revenue Next 2Y14.29%
Revenue Next 3Y17.83%
Revenue Next 5Y16.06%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 43.85, which means the current valuation is very expensive for SDGR.
Based on the Price/Earnings ratio, SDGR is valued a bit cheaper than the industry average as 76.92% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of SDGR to the average of the S&P500 Index (28.28), we can say SDGR is valued expensively.
The Forward Price/Earnings Ratio is negative for SDGR. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 43.85 | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
SDGR's earnings are expected to decrease with -77.01% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-157.73%
EPS Next 3Y-77.01%
5. Dividend
5.1 Amount
No dividends for SDGR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SCHRODINGER INC
NASDAQ:SDGR (5/3/2024, 7:17:38 PM)
After market: 23.4716 -0.21 (-0.88%)23.68
+0.49 (+2.11%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.72B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 43.85 | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.07% | ||
| ROE | 7.42% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | 18.8% | ||
| GM | 64.93% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 4.25 | ||
| Quick Ratio | 4.25 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)125.78%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-629.76%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)19.74%
Revenue growth 3Y26.08%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y